Triptan-induced Reversible Cerebral Vasoconstriction Syndrome Presenting With Thunderclap Headache and Paraparesis

Reversible cerebral vasoconstriction syndrome is a rare clinical syndrome characterized by sudden thunderclap headache often an under diagnosed neurological emergency. It is often provoked by postpartum state or exposure to provocative drugs. We report a rare case of Rizatriptan-induced reversible cerebral vasoconstriction syndrome presenting with thunderclap headache and paraparesis with complete recovery of neurological and imaging findings.

[1]  A. Singhal,et al.  Glucocorticoid-associated worsening in reversible cerebral vasoconstriction syndrome , 2017, Neurology.

[2]  N. Tanahashi,et al.  Triptan-induced Reversible Cerebral Vasoconstriction Syndrome: Two Case Reports with a Literature Review , 2016, Internal medicine.

[3]  Yen-Feng Wang,et al.  Recurrence of reversible cerebral vasoconstriction syndrome , 2015, Neurology.

[4]  A. Ducros Reversible cerebral vasoconstriction syndrome , 2012, The Lancet Neurology.

[5]  P. Hantson,et al.  Reversible Cerebral Vasospasm, Multilobular Intracerebral Hemorrhages, and Nonaneurysmal Subarachnoid Hemorrhage: Review of Possible Interrelationships , 2010, Current pain and headache reports.

[6]  A. Ducros Syndrome de vasoconstriction cérébrale réversible , 2010 .

[7]  A. Straube,et al.  Reversible Cerebral Vasoconstriction Syndrome: A Complicated Clinical Course Treated with Intra-Arterial Application of Nimodipine , 2009, Cephalalgia : an international journal of headache.

[8]  R. Porcher,et al.  The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. , 2007, Brain : a journal of neurology.

[9]  A. Singhal,et al.  Narrative Review: Reversible Cerebral Vasoconstriction Syndromes , 2007, Annals of Internal Medicine.

[10]  A. Singhal Cerebral Vasoconstriction Syndromes , 2004, Topics in stroke rehabilitation.

[11]  V. Caviness,et al.  Cerebral vasoconstriction and stroke after use of serotonergic drugs , 2002, Neurology.